Google (NASDAQ:GOOG) to Establish New Class of Capital Stock; RTI Surgical (NASDAQ:RTIX), GenMark Diagnostics (NASDAQ:GNMK)

Technology Stocks News 16

According to theflyonthewall.com Google (NASDAQ:GOOG) is establishing a new class of capital stock and is paying a dividend of one share of this new class of capital stock for each outstanding share of Class A and Class B common stock. Both Google Class A and Google Class C will be included in the S&P 500 and S&P 100 and there will not be a switch from Class A to Class C on June 20th as previously announced in a press release dated February 3.

Google (GOOG) finished down .96% in Tuesday trading, closing at 1,199.99. The company holds a P/E ratio of 33.29 and has a market cap of 403.26 billion. The 52-week range of the stock is 1,196.64 – 1,214.32.

In other news

RTI Surgical (NASDAQ:RTIX) is surging higher in late trade after the company said that it has received approval to CE mark Fortiva Porcine Dermis and will begin distribution throughout Europe. Shares are up 26% at $4.98, and will surpass the 52-week high of $4.53 if they continue their upward movement in tomorrow’s regular session.

The company’s Fortiva porcine dermis is a non-crosslinked acellular porcine dermal matrix intended for use as a soft tissue path to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes. The implant is indicated for use in repairing hernias and/or body wall defects that require the use of reinforcing or bridging material to obtain the desired surgical outcome.

Fortiva received 510(k) clearance from the U.S. Food and Drug and Administration (FDA) in March 2013 and was launched in the U.S. in July 2013. The implant is manufactured at RTIX’s Neunkirchen, Germany facility.

GenMark Diagnostics (NASDAQ:GNMK) is little moved after hours Tuesday after the molecular diagnostics company reports a wider Q4 loss on weaker revenue than in the same quarter a year earlier.

GenMark (GNMK) reported a Q4 net loss of $8.6 million, or $0.21 per diluted share, less items, compared to a loss of $4.7 million or $0.15 per share a year earlier. The company reported revenue of $6.5 million, down from $9.4 million for Q4 2012. Capital IQ did not provide analyst estimates. Shares of GenMark (GNMK) are unchanged in after hours trading at $12.07, with a 52-week range of $8.75 to $16.00.

 

 

 

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone